Treatment of iron deficiency anaemia with the natural hematinic Carbaodeim

Mugahid Faroug Mohamed Ali1, Mohammed Osman Swar2, Atika Mohamed Osman2

  • 1Aljauda Hospital , Khartoum , Sudan.

Insights

A natural hematinic blend, Carboadeim, effectively treats iron deficiency anaemia in children. This cost-effective treatment, made from carrots, baobab, and godeim, offers a viable alternative to standard iron supplements.

Area of Science:

  • Pediatric Hematology
  • Nutritional Science
  • Natural Product Medicine

Background:

  • Iron deficiency anaemia is prevalent in children, necessitating accessible and compliant treatment options.
  • Treatment modifications based on local resources can improve patient outcomes.
  • Traditional and natural remedies are increasingly explored for managing nutritional deficiencies.

Purpose of the Study:

  • To compare the efficacy of a natural hematinic blend (Carboadeim) with standard iron and folic acid treatment for paediatric iron deficiency anaemia.
  • To evaluate the accessibility and compliance of a locally sourced natural hematinic in a resource-limited setting.

Main Methods:

  • A prospective, interventional, controlled, hospital-based study was conducted on children with iron deficiency anaemia.
  • Participants were randomized into two groups: one receiving iron syrup plus folic acid (control), and the other receiving Carboadeim (carrots, baobab, Grewia tenax).
  • Hematological parameters including complete blood count, reticulocyte count, and serum ferritin were monitored at baseline and at intervals up to 3 months.

Main Results:

  • Both groups showed significant improvement in mean hemoglobin levels after 3 months (Carboadeim: 11.67 gm/dL, Control: 11.384 gm/dL).
  • Mean serum ferritin levels increased in both groups, with Carboadeim showing a mean of 44.34 ng/ml compared to 75.7 ng/ml in the control group after 3 months.
  • Initial mean hemoglobin levels were similar in both groups (Case: 7.38 gm/dL, Control: 7.35 gm/dL).

Conclusions:

  • Carboadeim is a naturally available and cost-effective hematinic that demonstrates positive therapeutic response in children with nutritional anaemia.
  • The natural blend can be considered as a food supplement and a treatment option for nutritional anaemia in pediatric populations.
  • Modifying treatment with locally available resources like Carboadeim can enhance treatment accessibility and compliance.

Related Concept Videos

Carboxylic Acids to Primary Alcohols: Hydride Reduction01:17

Carboxylic Acids to Primary Alcohols: Hydride Reduction

Carboxylic acids, upon reaction with strong reducing agents such as lithium aluminum hydride followed by hydrolysis, undergo reduction to form primary alcohols.
5.5K
Preparation of Acid Anhydrides01:07

Preparation of Acid Anhydrides

One of the methods for preparing symmetrical or unsymmetrical acid anhydrides involves the treatment of acid chlorides with the sodium salt of carboxylic acids. The reaction proceeds via a nucleophilic acyl substitution.
The carboxylate ion acts as a nucleophile that attacks the carbonyl carbon of the acid chloride to form a tetrahedral intermediate. Subsequently, the re-formation of the carbonyl group with the loss of the chloride ion as a leaving group leads to the formation of an acid...
4.2K
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
833
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.6K
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
713